1h Free Analyst Time
The rapid microbiology testing market is poised to grow by $2,487.91 mn during 2023-2027, accelerating at a CAGR of 9.31% during the forecast period. The report on the rapid microbiology testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence of infectious disease and cancer, rise in geriatric population, and the high prevalence of food-borne diseases.
The rapid microbiology testing market is segmented as below:
By End-user
- Hospitals and diagnostic laboratories
- Pharmaceutical and biotechnology companies
- Others
By Geographical Landscape
- North America
- Asia
- Europe
- Rest of World (ROW)
The report on the rapid microbiology testing market covers the following areas:
- Rapid microbiology testing market sizing
- Rapid microbiology testing market forecast
- Rapid microbiology testing market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Method
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global rapid microbiology testing market: Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Biosensia Ltd., Bruker Corp., Charles River Laboratories, Colifast AS, Danaher Corp., Don Whitley Scientific Ltd., Euroclone SpA, Gradientech AB, Merck KGaA, Neogen Corp., Quidel Corp., Rapid Micro Biosystems Inc., rqMicro AG, Sartorius AG, Serosep Ltd., Solus Scientific Ltd., and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is rise in food safety concerns.`
According to the report, one of the major drivers for this market is the increasing incidence of infectious disease and cancer.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Becton Dickinson and Co.
- bioMerieux SA
- Biosensia Ltd.
- Bruker Corp.
- Charles River Laboratories
- Colifast AS
- Danaher Corp.
- Don Whitley Scientific Ltd.
- Euroclone SpA
- Gradientech AB
- Merck KGaA
- Neogen Corp.
- Quidel Corp.
- Rapid Micro Biosystems Inc.
- rqMicro AG
- Sartorius AG
- Serosep Ltd.
- Solus Scientific Ltd.
- Thermo Fisher Scientific Inc.
